OnKure Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	59.05	110.76	29.88	11.54
Cash & Short-Term Investments	59.05	110.76	29.88	11.54
Cash Growth	-46.69%	270.74%	158.82%	-
Prepaid Expenses	1.79	2.24	3.89	2.08
Total Current Assets	60.84	113	33.77	13.62
Property, Plant & Equipment	1.01	1.8	1.91	2.05
Other Long-Term Assets	0.27	0.11	0.06	0.33
Total Assets	62.12	114.91	35.73	16
Accounts Payable	1.43	2.97	3.42	2.52
Accrued Expenses	3.94	7.03	3.66	2.87
Current Portion of Leases	0.55	0.54	0.21	0.15
Total Current Liabilities	5.92	10.53	7.29	5.54
Long-Term Leases	-	0.55	0.47	0.49
Other Long-Term Liabilities	0.01	-	-	-
Total Liabilities	5.93	11.08	7.75	6.03
Common Stock	0	0	-	0
Additional Paid-In Capital	270.42	258.55	0.21	2.66
Retained Earnings	-214.24	-154.72	-102.05	-57.07
Total Common Equity	56.18	103.83	-101.84	-54.42
Shareholders' Equity	56.18	103.83	27.98	9.97
Total Liabilities & Equity	62.12	114.91	35.73	16
Total Debt	0.55	1.09	0.67	0.64
Net Cash (Debt)	58.5	109.68	29.2	10.91
Net Cash Growth	-46.66%	275.58%	167.76%	-
Net Cash Per Share	4.33	31.82	102.89	-
Filing Date Shares Outstanding	13.67	13.44	13.34	-
Total Common Shares Outstanding	13.67	13.35	13.34	-
Working Capital	54.92	102.47	26.48	8.08
Book Value Per Share	4.11	7.78	-7.63	-
Tangible Book Value	56.18	103.83	-101.84	-54.42
Tangible Book Value Per Share	4.11	7.78	-7.63	-
Machinery	0.99	1.05	1.01	0.85
Leasehold Improvements	1.09	1.09	1.09	1

Source: S&P Capital IQ. Standard template. Financial Sources.